AIM: To verify the usefulness of FibroQ for predicting fibrosis in patients with chronic hepatitis C, compared with other noninvasive tests. METHODS: This retrospective cohort study included 237 consecutive patients with chronic hepatitis C who had undergone percutaneous liver biopsy before treatment. FibroQ, aspartate aminotransferase (AST)/alanine aminotransferase ratio (AAR), AST to platelet ratio index, cirrhosis discriminant score, age-platelet index (API), Pohl score, FIB-4 index, and Lok's model were calculated and compared. RESULTS: FibroQ, FIB-4, AAR, API and Lok's model results increased significantly as fibrosis advanced (analysis of variance test: P < 0.001). FibroQ trended to be superior in predicting significant fibrosis score in chronic hepatitis C compared with other noninvasive tests. CONCLUSION: FibroQ is a simple and useful test for predicting significant fibrosis in patients with chronic hepatitis C.
AIM: To verify the usefulness of FibroQ for predicting fibrosis in patients with chronic hepatitis C, compared with other noninvasive tests. METHODS: This retrospective cohort study included 237 consecutive patients with chronic hepatitis C who had undergone percutaneous liver biopsy before treatment. FibroQ, aspartate aminotransferase (AST)/alanine aminotransferase ratio (AAR), AST to platelet ratio index, cirrhosis discriminant score, age-platelet index (API), Pohl score, FIB-4 index, and Lok's model were calculated and compared. RESULTS: FibroQ, FIB-4, AAR, API and Lok's model results increased significantly as fibrosis advanced (analysis of variance test: P < 0.001). FibroQ trended to be superior in predicting significant fibrosis score in chronic hepatitis C compared with other noninvasive tests. CONCLUSION: FibroQ is a simple and useful test for predicting significant fibrosis in patients with chronic hepatitis C.
Authors: Enrico Rossi; Leon Adams; Alexander Prins; Max Bulsara; Bastiaan de Boer; George Garas; Gerry MacQuillan; David Speers; Gary Jeffrey Journal: Clin Chem Date: 2003-03 Impact factor: 8.327
Authors: Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok Journal: Hepatology Date: 2003-08 Impact factor: 17.425
Authors: G Shiha; S Seif; A Eldesoky; M Elbasiony; R Soliman; A Metwally; K Zalata; N Mikhail Journal: Hepatol Int Date: 2017-04-19 Impact factor: 6.047
Authors: James F Crismale; Valérie Martel-Laferrière; Kian Bichoupan; Emily Schonfeld; Alexis Pappas; Christina Wyatt; Joseph A Odin; Lawrence U Liu; Thomas D Schiano; Ponni V Perumalswami; Meena Bansal; Douglas T Dieterich; Andrea D Branch Journal: Liver Int Date: 2013-10-25 Impact factor: 5.828
Authors: Roberta D'Ambrosio; Elisabetta Degasperi; Alessio Aghemo; Mirella Fraquelli; Pietro Lampertico; Maria Grazia Rumi; Floriana Facchetti; Eleonora Grassi; Giovanni Casazza; William Rosenberg; Pierre Bedossa; Massimo Colombo Journal: PLoS One Date: 2016-06-15 Impact factor: 3.240
Authors: Mette J Nielsen; Konstantin Kazankov; Diana J Leeming; Morten A Karsdal; Aleksander Krag; Francisco Barrera; Duncan McLeod; Jacob George; Henning Grønbæk Journal: PLoS One Date: 2015-09-25 Impact factor: 3.240